ClinicalTrials.Veeva

Menu

Intervening With Opioid-Dependent MothersMothers and Infants (mABC)

University of Delaware logo

University of Delaware

Status

Enrolling

Conditions

Parenting
Infant Development
Opioid Dependence

Treatments

Behavioral: mABC
Behavioral: mDEF

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04454645
mABC
1R01HD098525-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study will assess the efficacy of the modified Attachment and Biobehavioral Catch-Up (mABC) Intervention, adapted for use with peripartum mothers receiving medication-assisted treatment for opioid use disorder. The investigators expect that mothers who receive the modified Attachment and Biobehavioral Catch-up Intervention will show more nurturing and sensitive parenting and more adaptive physiological regulation than parents who receive a control intervention. The investigators expect that infants whose mothers receive the modified Attachment and Biobehavioral Catch-up will show better outcomes in attachment, behavior, and physiological regulation than infants of parents who receive the control intervention.

Full description

Pregnant mothers will be randomly assigned to receive the modified ABC intervention or the control intervention (modified DEF). Hypotheses relate to parent and child outcomes associated with the intervention. Hypothesis 1: Compared to mothers who receive the control intervention, mothers who receive the mABC intervention will show more nurturing and sensitive parenting, enhanced neural activity during parenting-relevant tasks, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production. Hypothesis 2: Compared to infants of mothers who receive the control intervention, infants of mothers who receive the mABC intervention will show more organized and secure attachment patterns, better behavioral regulation during stressors, more advanced social-emotional development, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production. Hypothesis 3: Enhanced maternal sensitivity will mediate effects of the mABC intervention on improved infant outcomes.

Enrollment

200 estimated patients

Sex

Female

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Opioid-dependent pregnant women in third trimester of pregnancy on medication-assisted treatment

Exclusion criteria

  • None

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

200 participants in 2 patient groups

Modified ABC
Experimental group
Description:
12-session home visiting intervention designed to increase parental sensitivity and nurturance and decrease parental frightening behavior.
Treatment:
Behavioral: mABC
Modified DEF
Active Comparator group
Description:
12-session home visiting intervention designed to increase parental playful interactions that stimulate infant cognitive and motor development
Treatment:
Behavioral: mDEF

Trial contacts and locations

1

Loading...

Central trial contact

Mary Dozier, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems